Cervical screenings would be no-cost

Summary#

SB 1527, “Relating to health care,” is enacted. It creates a new insurance requirement and amends Oregon statutes on health plan definitions and benefit plans offered by the Public Employees’ Benefit Board and Oregon Educators Benefit Board. Its stated goal is to prevent out-of-pocket charges for cervical cancer screening and medically necessary follow-up tests.

  • Health plans covered by the bill may not charge deductibles, coinsurance, copayments or other out-of-pocket costs for covered cervical cancer screenings and medically necessary follow-up examinations.
  • Follow-up exams include colposcopy, biopsy, and additional cytology or HPV tests, even if they use a different sample or happen on a different date.
  • The screening rule applies to a carrier offering a group or individual plan in Oregon that reimburses cervical cancer screenings. The bill does not itself require a plan to add screening coverage.
  • The rule does not cover services primarily for treating diagnosed cervical cancer. The bill also adds the requirement to benefit plans offered by the two state boards, including specified self-insured plans.
  • The law applies to policies issued, renewed or extended after its effective date; the effective date is not provided in the available text.

What it means for you#

  • People with covered group or individual health plans: If your plan reimburses cervical cancer screenings, you should not have to pay out of pocket for medically necessary screening or follow-up exams covered by the bill. The rule does not apply to treatment primarily for diagnosed cervical cancer.
  • Public employees and educators: Benefit plans offered by the Public Employees’ Benefit Board and Oregon Educators Benefit Board must comply for plans within the bill’s timing rules.
  • People with other types of coverage: The bill does not apply to every kind of health coverage. The amended definitions exclude some types of plans, including employee welfare plans exempt from state regulation under federal law.
  • Insurers and plan operators: They must follow the no-cost-sharing rule for the services it covers. The bill does not set out a claims process or appeals process.

Money#

No publicly available information on the public cost or expected effect on premiums.

  • The bill bars out-of-pocket charges for the specified services; it does not set a fee, fine, tax or funding amount.
  • Plans may face costs for services that patients previously paid for through cost-sharing. Any effect on plan costs or premiums is unknown.

What is unclear#

  • The available material does not give the effective date, so the exact start date cannot be confirmed.
  • The bill does not define “medically necessary” or explain how disputes about that standard would be handled.
  • The bill does not specify oversight, enforcement, reporting, or a process for patients to challenge a charge.
  • The parent statutes are not supplied, so the existing law and how much this changes current coverage rules could not be verified.
  • The material does not estimate how many people or plans will be affected, or how plans will handle any added costs.

Case for#

  • A possible argument for the bill is that patients may otherwise face charges for diagnostic tests needed after an abnormal screening result.
  • Removing cost-sharing for both screening and follow-up could reduce a financial barrier between an initial test and further evaluation.
  • Listing examples such as biopsy and colposcopy makes clear that the rule reaches beyond the first screening test.

Case against#

  • One concern is that plans may have to pay more for services patients previously paid for in part; the bill provides no estimate of the effect on plan costs or premiums.
  • The meaning of “medically necessary” is not set out in the bill, which could leave uncertainty about which follow-up services qualify.
  • The bill does not explain how it will be enforced or how patients can resolve disputes over charges.

Votes

2 recorded votes on this bill, newest first.

  1. Division No. 1628351

    Passed29 members voted

    Senate Third Reading

    FOR · 29

    Each dot is one member. Hover or tap one to see who.

    29For

    • Democratic18
    • Republican11

    0Against

    1 member was paired and sat out the vote.

  2. Division No. 1623524

    Passed5 members voted

    Senate Committee Do pass with amendments. (Printed A-Eng.)

    FOR · 5

    Each dot is one member. Hover or tap one to see who.

    5For

    • Democratic3
    • Republican2

    0Against